The Ministry of Health's Cabinet Secretary Mr Mutahi Kagwe has informed the public that the Head of State President Uhuru Kenyatta led Jubilee government has made an assurance of having additional Corona virus disease vaccine in the country before next week ends.
Kenyans who have already received their first dose of the AstraZeneca COVID-19 vaccine will start receiving their second dose from next week.
The Ministry of Health has established that another 130,000 doses of Corona Virus disease vaccine are expected to be jetted in the country soon from COVAX.
This is good news for many Kenyans as some of them will now received their first dose while others who had already received their first dose will be given the second one.
The government through the Ministry of Health has informed the public that those when had already received their first dose of AstraZeneca vaccine are set to start receiving their second dose as from next week.
Content created and supplied by: QuickServe (via Opera News )
Opera News is a free to use platform and the views and opinions expressed herein are solely those of the author and do not represent, reflect or express the views of Opera News. Any/all written content and images displayed are provided by the blogger/author, appear herein as submitted by the blogger/author and are unedited by Opera News. Opera News does not consent to nor does it condone the posting of any content that violates the rights (including the copyrights) of any third party, nor content that may malign, inter alia, any religion, ethnic group, organization, gender, company, or individual. Opera News furthermore does not condone the use of our platform for the purposes encouraging/endorsing hate speech, violation of human rights and/or utterances of a defamatory nature. If the content contained herein violates any of your rights, including those of copyright, and/or violates any the above mentioned factors, you are requested to immediately notify us using via the following email address operanews-external(at)opera.com and/or report the article using the available reporting functionality built into our Platform See More